Cargando…

Bilirubin: A Potential Biomarker and Therapeutic Target for Diabetic Nephropathy

Detalles Bibliográficos
Autores principales:	Hull, Travis D., Agarwal, Anupam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2014
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113062/ https://www.ncbi.nlm.nih.gov/pubmed/25060893 http://dx.doi.org/10.2337/db14-0691

Ejemplares similares

Bilirubin: Striking Gold in Diabetic Vasculopathy?
por: Durante, William
Publicado: (2015)

Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment
por: Badal, Shawn S., et al.
Publicado: (2015)

Biomarkers That Predict Diabetic Nephropathy: The Long Road From Finding Targets to Clinical Use
por: Klein, Jon
Publicado: (2012)

Cholesterol Accumulation in Podocytes: A Potential Novel Targetable Pathway in Diabetic Nephropathy
por: Tufro, Alda
Publicado: (2013)

Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy
por: de Haan, Judy B.
Publicado: (2011)

Transgelin in bladder cancer: A potential biomarker and therapeutic target
por: Li, Wei-Ming, et al.
Publicado: (2019)

Values and Limitations of Targeting lncRNAs in Diabetic Nephropathy
por: Long, Jianyin, et al.
Publicado: (2018)

Effect of Bilirubin on Triglyceride Synthesis in Streptozotocin-Induced Diabetic Nephropathy
por: Xu, Jianwei, et al.
Publicado: (2014)

Identification of potential biomarkers and therapeutic targets for human IgA nephropathy and hypertensive nephropathy by bioinformatics analysis
por: Cui, Yingchun, et al.
Publicado: (2017)

The Challenging Search for Diabetic Nephropathy Genes
por: Bowden, Donald W., et al.
Publicado: (2012)

Bioinformatic gene analysis for potential biomarkers and therapeutic targets of diabetic nephropathy associated renal cell carcinoma
por: Dong, Yunze, et al.
Publicado: (2020)

Bone-kidney axis: A potential therapeutic target for diabetic nephropathy
por: Yang, Ming, et al.
Publicado: (2022)

Urinary adiponectin and progression of diabetic nephropathy in type 1 diabetes
por: Ha, Kyoung Hwa, et al.
Publicado: (2015)

Losartan and diabetic nephropathy: commentaries on the RENAAL study
por: Fisman, Enrique Z, et al.
Publicado: (2002)

Complement in Lupus: Biomarker, Therapeutic Target, or a Little Bit of Both?
por: Cantarelli, Chiara, et al.
Publicado: (2021)

Autophagy as a Therapeutic Target in Diabetic Nephropathy
por: Tanaka, Yuki, et al.
Publicado: (2012)

Contrast-induced nephropathy: attributable incidence and potential harm
por: de Freitas do Carmo, Lilian Pires, et al.
Publicado: (2012)

CREDENCE: A silver lining in the dark cloud of diabetic nephropathy
por: Hanai, Ko, et al.
Publicado: (2019)

Vitamin D in diabetic nephropathy
por: Prabhu, RA, et al.
Publicado: (2018)

Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy
por: Liu, Na, et al.
Publicado: (2017)

Metabonomic analysis of potential biomarkers and drug targets involved in diabetic nephropathy mice
por: Wei, Tingting, et al.
Publicado: (2015)

Myokines: Novel therapeutic targets for diabetic nephropathy
por: Yang, Ming, et al.
Publicado: (2022)

Autophagy and its therapeutic potential in diabetic nephropathy
por: Han, Yu-Peng, et al.
Publicado: (2023)

Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy
por: Nishikawa, Takeshi, et al.
Publicado: (2015)

Epidermal growth factor receptor signaling and the progression of diabetic nephropathy
por: Koya, Daisuke
Publicado: (2015)

Exosomes in Diabetic Cardiomyopathy: The Next-Generation Therapeutic Targets?
por: Sahoo, Susmita, et al.
Publicado: (2016)

Prediction of the molecular mechanisms and potential therapeutic targets for diabetic nephropathy by bioinformatics methods
por: WANG, WAN-NING, et al.
Publicado: (2016)

Relationship between serum bilirubin concentrations and diabetic nephropathy in Shanghai Han’s patients with type 1 diabetes mellitus
por: Li, Xu, et al.
Publicado: (2017)

Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
por: Davidson, Michael H.
Publicado: (2015)

Urinary angiotensinogen as a potential biomarker of diabetic nephropathy
por: Satirapoj, Bancha, et al.
Publicado: (2014)

Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: Towards therapeutic targets and biomarkers
por: Akiyama, Tetsuya, et al.
Publicado: (2022)

Autophagy: A Novel Therapeutic Target for Diabetic Nephropathy
por: Kume, Shinji, et al.
Publicado: (2015)

Total bilirubin level may be a biomarker of nephropathy in type 2 diabetes mellitus: A meta-analysis of observational studies based on MOOSE compliant
por: Zhang, Dan, et al.
Publicado: (2017)

Does Losartan Prevent Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes?
por: Nicholas, Susanne B., et al.
Publicado: (2013)

Identifying genes that regulate bone remodeling as potential therapeutic targets
por: Krane, Stephen M.
Publicado: (2005)

Therapeutic Targeting of B Cells and T Cells in Autoimmune Diabetes: Is It a Solution?
por: Chatenoud, Lucienne
Publicado: (2013)

Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity
por: Usui, Ryota, et al.
Publicado: (2019)

Developments in the Role of Endothelin-1 in Atherosclerosis: A Potential Therapeutic Target?
por: Sutton, Greg, et al.
Publicado: (2019)

Plasma-type gelsolin in subarachnoid hemorrhage: novel biomarker today, therapeutic target tomorrow?
por: Chou, Sherry Hsiang-Yi, et al.
Publicado: (2014)

The missing middle of sickle therapeutics: Multi‐agent therapy, targeting risk, using biomarkers
por: Hebbel, Robert P., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6im3t8ctgacesqsg40sm8hts48